Macrophage Activation Syndrome (MAS)
Showing 1 - 25 of >10,000
Macrophage Activation Syndrome Trial in Birmingham (kineret, )
Active, not recruiting
- Macrophage Activation Syndrome
- kineret
- placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2021
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)
Not yet recruiting
- Macrophage Activation Syndrome
- (no location specified)
Mar 16, 2022
Toxicities in Children and Adults With Cancer
Active, not recruiting
- Macrophage Activation Syndrome
- Primary Hemophagocytic Lymphohistiocytosis
-
Bethesda, MarylandNational Cancer Institute (NCI)
Sep 17, 2022
Genetics, and Pathophysiology of Systemic Juvenile Idiopathic
Recruiting
- Still's Disease, Adult-Onset
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation
Completed
- Acute Respiratory Distress Syndrome
- Mechanical Ventilation
- RAGE TXNIP Inflammasome axis
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
May 9, 2020
Covid19, Pneumonia, Cytokine Release Syndrome Trial in Doha (Anakinra, Standard of Care)
Completed
- Covid19
- +4 more
- Anakinra
- Standard of Care
-
Doha, QatarHamad Medical Corporation
Aug 15, 2022
SARS-CoV-2 Infection Trial in Switzerland (Tocilizumab (TCZ), Placebo)
Terminated
- SARS-CoV-2 Infection
- Tocilizumab (TCZ)
- Placebo
-
Bern, Switzerland
- +3 more
Oct 12, 2020
Mast Cell Activation Syndrome in EDS With Digestive Disorders
Recruiting
- Ehlers Danlos Hypermobile Syndrome
- Determine the presence of mast cell activation syndrome
-
Lille, Nord, FranceSaint-Vincent-de-Paul hospital
Jan 10, 2023
Sepsis, Macrophage Activation Syndrome Trial in Greece (Anakinra, Recombinant human interferon-gamma, Placebo)
Completed
- Sepsis
- Macrophage Activation Syndrome
- Anakinra
- +2 more
-
Athens, Haidari, Greece
- +12 more
Jul 28, 2020
Novel Factors Leading to Activated Macrophage Expansion in
Active, not recruiting
- Covid19
- SARS-CoV-2 Infection
- Soton hyperinflammation score
- HScore
-
Southampton, Hampshire, United KingdomUniversity Hospitals Southampton NHS Foundation Trust
May 25, 2021
COVID-19 Prospective Cohort for Identification of Secondary HLH
Unknown status
- COVID
-
München, Bavaria, GermanyDepartment of nephrology, Klinikum rechts der Isar
Apr 11, 2020
Acute Respiratory Distress Syndrome, Ventilator Associated Pneumonia Trial in Denver (Non-Bronchoscopic Mini Bronchoalveolar
Recruiting
- Acute Respiratory Distress Syndrome
- Ventilator Associated Pneumonia
- Non-Bronchoscopic Mini Bronchoalveolar Lavage
-
Denver, ColoradoIntermountain Health - St. Joseph's Hospital - National Jewish H
Mar 2, 2023
Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)
Recruiting
- Advanced Solid Tumor
- B4T2-001 autologous CAR-T
-
Shanghai, China/Shanghai, China
- +1 more
Oct 3, 2023
COVID-19 Trial in Brussels (Cytokines dosage, Complement dosage)
Completed
- COVID-19
- Cytokines dosage
- Complement dosage
-
Brussels, BelgiumCHU Brugmann
Sep 28, 2021
Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia Trial in New York (CD34 Stem Cell Selection
Active, not recruiting
- Bone Marrow Failure Syndrome
- +15 more
- CD34 Stem Cell Selection Therapy
-
New York, New YorkMorgan Stanley Children's Hospital, New York-Presbyterian, Colum
Jun 17, 2020
Solid Tumors Trial in Kashiwa, Nishinomiya, Chuo-ku (TAK-103)
Recruiting
- Solid Tumors
- TAK-103
-
Kashiwa, Chiba, Japan
- +2 more
Mar 10, 2022
ARDS Trial in Nanjing
Recruiting
- ARDS
-
Nanjing, Jiangsu, ChinaNanjing Zhong-Da Hospital, Southeast University
Jul 17, 2022
COVID-19 Pnemonia Trial in Spain (Anakinra 149 MG/ML Prefilled Syringe [Kineret])
Completed
- COVID-19 Pnemonia
- Anakinra 149 MG/ML Prefilled Syringe [Kineret]
-
Zaragoza, Aragón, Spain
- +11 more
May 27, 2021
Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T
Recruiting
- Anaplastic Thyroid Cancer
- Relapsed/Refractory Poorly Differentiated Thyroid Cancer
- AIC100 CAR T Cells
-
New York, New YorkWeill Cornell Medical College
Feb 14, 2022
Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +7 more
-
Brussels, Brussel, BelgiumUz Brussel
Sep 2, 2022
SARS (Disease) Trial in Houston (Cyclosporine, Standard of Care Treatment)
Recruiting
- SARS (Disease)
- Cyclosporine
- Standard of Care Treatment
-
Houston, TexasBaylor College of Medicine
Oct 26, 2021
Diabetes, Gastroparesis With Diabetes Trial in Rochester (PET/CT Scan with 11C-ER176, Core biopsy of gastric muscle)
Active, not recruiting
- Diabetes
- Gastroparesis With Diabetes Mellitus
- PET/CT Scan with 11C-ER176
- Core biopsy of gastric muscle
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 11, 2022